NeuroMab™ Anti-CD38 Antibody(NRP-0422-P2243)

[CAT#: NRP-0422-P2243]

A therapeutic antibody raised against Human CD38.

Host Species:: Human

Species Reactivity:: Human

Applications:: WB; ELISA; FC; IHC; Inhib; Block; In Vitro; In Vivo

Certificate of Analysis Lookup
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number

Inquiry

Product Overview

Description

NRP-0422-P2243 is a targeted therapy (IgG1k human monoclonal antibody) that targets CD38 and relates to a method of treating acute myelogenous leukemia.

Species Reactivity

Human

Clonality

Monoclonal

Host Species

Human

Isotype

IgG

Applications

WB; ELISA; FC; IHC; Inhib; Block; In Vitro; In Vivo

Relevant Diseases

Parkinson's Disease; Multiple Sclerosis

Product Properties

Formulation

PBS only

Preservatives

BSA Free

Concentration

1mg/mL

Purification

Purified recombinant IgG prepared by affinity chromatography on Protein A from a mammalian cell line

Purity

>95% by SDS PAGE or HPLC

Endotoxin Level

Regular Endotoxin < 5 EU/mg
Low Endotoxin < 1 EU/mg

Shipping

Gel Packs

Storage

Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

Research Use Only

For research use only

Target

CD38

Official Name

CD38

Full Name

CD38 molecule

Alternative Names

Acute lymphoblastic leukemia cells antigen CD38;
ADP ribosyl cyclase 1;
ADP ribosyl cyclase;
ADP ribosyl cyclase/cyclic ADP-ribose hydrolase;
ADP-ribosyl cyclase 1;
ADPRC 1;
ADPRC1;
cADPr hydrolase 1;
CD 38;